尊龙凯时人生就是搏·(中国区)官方网站
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2021
2021.12.06
ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES - FACILITY AGREEMENT WITH SPECIFIC PERFORMANCE COVENANTS
2021.12.01
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2021.11.08
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2021
2021.11.01
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE FIRST GENERIC “COLISTIMETHATE SODIUM FOR INJECTION” FOR MARKETING
2021.10.15
2021 INTERIM REPORT
2021.09.24
2020 ANNUAL REPORT
2021.04.22
Interim Report 2020
2020.09.23
首页
上一页
43
44
45
46
47
48
...
53
尾页
下一页